From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients

Journal of the American Academy of Dermatology

Volumn 56, Issue 5, 2007, Pages 748-752

  de Snoo, Femke A ^a   Kroon, Marije W ^b   Bergman, Wilma ^b   ter Huurne, Jeanet A C ^a   Houwing Duistermaat, Jeanine J ^c   van Mourik, Leny ^a   Snels, Dyon G C T M ^b   Breuning, Martijn H ^a   Willemze, Rein ^b   Frants, Rune R ^a   Gruis, Nelleke A ^b  

^a Departments of Human and Clinical Genetics   (Netherlands)

^b Dermatology

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CDKN2A GENE; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE CLASSIFICATION; DYSPLASTIC NEVUS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; FOUNDER EFFECT; GENE; GENETIC SUSCEPTIBILITY; GERM LINE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUTATIONAL ANALYSIS; NETHERLANDS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; DNA MUTATIONAL ANALYSIS; DYSPLASTIC NEVUS SYNDROME; GERM-LINE MUTATION; HUMANS; MALE; MELANOMA; MIDDLE AGED; RISK ASSESSMENT; SKIN NEOPLASMS;

EID: 34147179977     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.01.010     Document Type: Article

References (16)

1. Clark Jr. W.H., Elder D.E., Guerry D., Epstein M.N., Greene M.H., and Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15 (1984) 1147-1165
2. Bataille V., Bishop J.A., Sasieni P., Swerdlow A.J., Pinney E., Griffiths K., et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 73 (1996) 1605-1611
3. Lynch H.T., Frichot III B.C., and Lynch J.F. Familial atypical multiple mole-melanoma syndrome. J Med Genet 15 (1978) 352-356
4. Zuo L., Weger J., Yang Q., Goldstein A.M., Tucker M.A., Walker G.J., et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12 (1996) 97-99
5. Randerson-Moor J.A., Harland M., Williams S., Cuthbert-Heavens D., Sheridan E., Aveyard J., et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 10 (2001) 55-62
6. Rizos H., Puig S., Badenas C., Malvehy J., Darmanian A.P., Jimenez L., et al. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 20 (2001) 5543-5547
7. Hewitt C., Lee W.C., Evans G., Howell A., Elles R.G., Jordan R., et al. Germline mutation of ARF in a melanoma kindred. Hum Mol Genet 11 (2002) 1273-1279
8. Harland M., Taylor C.F., Bass S., Churchman M., Randerson-Moor J.A., Holland E.A., et al. Intronic sequence variants of the CDKN2A gene in melanoma pedigrees. Genes Chromosomes Cancer 43 (2005) 128-136
9. Hille E.T., van Duijn E., Gruis N.A., Rosendaal F.R., Bergman W., and Vandenbroucke J.P. Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994. J Invest Dermatol 110 (1998) 788-792
10. Goldstein A.M., Martinez M., Tucker M.A., and Demenais F. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families. Cancer Epidemiol Biomarkers Prev 9 (2000) 889-894
11. Bishop J.A., Wachsmuth R.C., Harland M., Bataille V., Pinney E., Mac K.P., et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 114 (2000) 28-33
12. Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Abeni D., Boyle P., et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41 (2005) 28-44
13. Coebergh J.W., Janssen-Heijnen M.L.G., Louwman W.J., and Voogd A.C. Cancer incidence and survival in the South of the Netherlands, 1955-1999: a report of the Eindhoven Cancer Registry with cross-border implications (2001), Comprehensive Cancer Centre South (IKZ), Eindhoven 34-35
14. Celebi J.T., Ward K.M., Wanner M., Polsky D., and Kopf A.W. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome. Clin Exp Dermatol 30 (2005) 68-70
15. Matsumura Y., Nishigori C., and Miyachi Y. Analysis of the p16 gene status of non-familial dysplastic nevus syndrome patients. Arch Dermatol Res 293 (2001) 540-542
16. Ung-Juurlink C. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma. J Am Acad Dermatol 41 (1999) 461-462